These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2483443)

  • 1. Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure.
    Missale C; Metra M; Sigala S; Memo M; Dei Cas L; Spano PF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S72-6. PubMed ID: 2483443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood levels of activated renin, aldosterone, catecholamine in congestive heart failure. II. Effects of dopaminergic stimulation with a dopamine agonist: ibopamine].
    Melloni R; Scarazatti E; Gandini C; Melloni GF
    Boll Soc Ital Biol Sper; 1987 Dec; 63(12):1121-8. PubMed ID: 3331290
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview.
    Missale C; Lombardi C; De Cotiis R; Memo M; Carruba MO; Spano PF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S29-39. PubMed ID: 2483440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure].
    Nakano T; Isaka N; Konishi T; Tekezawa H; Morimoto Y; Kakuta Y; Kodera T; Kanamaru M
    Kokyu To Junkan; 1987 May; 35(5):553-9. PubMed ID: 3112884
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
    Metra M; Missale C; Spano PF; Cas LD
    J Cardiovasc Pharmacol; 1995 May; 25(5):732-40. PubMed ID: 7630152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and humoral effects of ibopamine, a dopamine agonist, in patients with liver cirrhosis.
    Salerno F; Incerti P; Badalamenti S; Lorenzano E; Graziani G; Morganti A; Ghirardi P
    Arch Intern Med; 1990 Jan; 150(1):65-9. PubMed ID: 1967522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapeutic profile of ibopamine in heart failure.
    Taylor SH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S118-23. PubMed ID: 2483437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T; Morimoto Y; Kakuta Y; Konishi T; Kodera T; Kanamaru M; Takezawa H
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
    G Ital Cardiol; 1989 Jan; 19(1):71-80. PubMed ID: 2663585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral and renal effects of ibopamine in normal subjects.
    Incerti PL; Badalamenti S; Lorenzano E; Graziani G; Morganti A; Salerno F; Ghirardi P
    Arzneimittelforschung; 1986 Feb; 36(2A):405-7. PubMed ID: 3518727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.
    Alicandri C; Fariello R; Boni E; Zaninelli A; Muiesan G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S77-82. PubMed ID: 2483444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ibopamine--acute hemodynamic, renal and neurohumoral effects].
    Wehling M; Theisen K
    Z Kardiol; 1991; 80 Suppl 8():67-9. PubMed ID: 1686694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure.
    Musacci GF; Ansani L; Toselli T; Aggio S; Baracca E; Longhini C
    Arzneimittelforschung; 1986 Feb; 36(2A):380-2. PubMed ID: 3707654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma renin activity and aldosterone concentration of patients with congestive cardiomyopathy].
    Popovich MI; Zatushevskiĭ IF; Botnar' VI
    Ter Arkh; 1986; 58(11):65-7. PubMed ID: 3547749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of prolactin and aldosterone secretion by the dopamine derivative ibopamine.
    Rolandi E; Marchetti G; Franceschini R; Cicchetti V; Gianrossi R; Cantoni V; Barreca T
    Eur J Clin Pharmacol; 1986; 29(5):629-30. PubMed ID: 3956568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
    Sannia L; Ibba GV; Castellaccio M; Dore L
    Arzneimittelforschung; 1986 Feb; 36(2A):355-9. PubMed ID: 3707649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of ibopamine on different diseases and conditions.
    Ventresca GP; Lodola E
    Arzneimittelforschung; 1988 Aug; 38(8):1175-80. PubMed ID: 2904270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure.
    Caponnetto S; Terrachini V; Canale C; Bruzzone F; Licciardello L; Marchetti GV
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S104-10. PubMed ID: 2483435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute changes in plasma renin activity, plasma aldosterone concentration and plasma electrolyte concentrations following furosemide administration in patients with congestive heart failure--interrelationships and diuretic response.
    Mulder H; Schopman W; van der Lely AJ; Schopman W
    Horm Metab Res; 1987 Feb; 19(2):80-3. PubMed ID: 3549504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.